Increase of Antibacterial Therapy Efficacy in Chronic Sepsis with Cycloferon and Reamberin Combination

Increase of Antibacterial Therapy Efficacy in Chronic Sepsis with Cycloferon and Reamberin Combination

The use of reamberin and cycloferon combination for increasing the antibacterial therapy efficacy in patients with chronic sepsis (CS) was studied. It was shown that the combination provided more rapid elimination of the CS exacerbation symptoms, normalization of the hematologic indices, bacteriemia...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. M. Frolov, N. A. Peresadin, R. B. Chkhetiany, O. V. Kruglova
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Subjects:	chronic sepsis pathogenesis antibacterial therapy cytokines cycloferon reamberin
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/437
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The influence of reamberin on oxygen balance, oxidative stress and lung dysfunction in patients with abdominal sepsis
by: A. B. Tolkach, et al.
Published: (2012-06-01)

Comparative evaluation of safety parameters at the preclinical and clinical stages of the study of the Reamberin® (LLC "POLYSAN")
by: V. B. Vasilyuk, et al.
Published: (2022-12-01)

Cycloferon Efficacy of Therapy of Chronic Hepatitis B (Results of Randomized Multicentre Study)
by: T. V. Sologub, et al.
Published: (2020-05-01)

Cycloferon in Complex Medicamentous Management of Chronic Laryngitis
by: E. V. Demchenko, et al.
Published: (2020-05-01)

Clinical Efficacy of Cycloferon in Complex Therapy of Infectious Mononucleosis in Pediatrics
by: E. B. Kasymova, et al.
Published: (2020-05-01)

Comparative Study of Hepatoprotective Action of Remaxol, Reamberin and Ademethionine in Liver Injury Induced by Antituberculosis Drugs (Experimental Study)
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

Experimental and Clinicolaboratory Evaluation of Complex Therapy Efficacy in Arboviral Infections
by: M. G. Romatsov, et al.
Published: (2020-05-01)

Evaluation of Safety and Pharmacotherapeutic Efficacy of Cycloferon in Treatment of Astrakhan Rickettsial Fever
by: YU. V. Sherysheva, et al.
Published: (2020-05-01)

Type 1 and Type 2 Interferon Inductor (Cycloferon) in Therapy of Children with Pyelonephritis Associated with Herpes Viruses
by: S. B. Orekhova, et al.
Published: (2020-05-01)

Cycloferon Therapy of Acute and Chronic Virus Hepatitis C
by: V. P. Malyy, et al.
Published: (2020-05-01)

Cycloferon Therapy of Chronic Gastroduodenitis in Children
by: S. Yu. Yermak, et al.
Published: (2020-05-01)

Cycloferon as an Agents of Antirelpsing Therapy in Patients with Chronic Hyperplastic Sinusitis
by: I. P. Vasilenko, et al.
Published: (2020-05-01)

Monitoring of Side Effects and Estimation of Cycloferon Efficacy in Treatment of Children with Frequent and Prolonged Diseases
by: S. A. Lyalikov, et al.
Published: (2020-05-01)

Immunomodulators in Therapy of Respiratory Infections
by: V. A. Isakov, et al.
Published: (2020-05-01)

Kinetics of Virus Load HCV-RNA in Blood Serum and Peripheral Mononuclear Cells in a Patient with Hepatocirrhosis and Chronic Virus Hepatitis C Termination Treated According to Noninterferon Treatment Scheme (Cycloferon + Ribavirin)
by: V. C. Stelmah, et al.
Published: (2020-05-01)

When to start antibiotic therapy in patients with sepsis in the ICU?
by: V. A. Rudnov, et al.
Published: (2020-11-01)

The Clinical Course and Correction of Metabolic Disturbances in Patients with Severe Methadone Poisoning
by: B. V. Batotsyrenov, et al.
Published: (2013-04-01)

Virus Infections and Interferon Inductors in the Complex Therapy
by: M. G. Romantsov, et al.
Published: (2020-05-01)

The role of cycloferon in the treatment of chronic Helicobacter pyloriinduced gastritis with gastric erosions associated with Epstein – Barr virus
by: T. E. Afanasenkova, et al.
Published: (2022-02-01)

Intrauterine inflammation exposure may increase the risk of late-onset sepsis in premature infants: a retrospective cohort study
by: Xiafang Chen, et al.
Published: (2025-07-01)

Cycloferon Efficiency in Children's and Adults' Hepatitis B and C Treatment: Systematic Review and Meta-Analysis Results
by: N. K. Mazina, et al.
Published: (2020-05-01)

MONOCYTE SUBSETS IN HEALTHY ADULTS AND SEPSIS PATIENTS
by: A. A. Kalashnikova, et al.
Published: (2018-12-01)

EFFECTIVENESS OF REAMBERIN IN CORRECTION OF OXIDATIVE STRESS SYNDROME IN PATIENTS WITH PHLEGMONOUS AND GANGRENOUS ERYSIPELAS AGAINST THE BACKGROUND OF THE 2 TYPE DIABETES MELLITUS
by: I. I. Zeleny, et al.
Published: (2018-01-01)

CYTOKINE REGULATION OF RESPIRATORY BURST IN BLOOD NEUTROPHILS FOR PREDICTION OF ABDOMINAL SEPSIS IN PATIENTS WITH EXTENDED PURULENT PERITONITIS
by: A. A. Savchenko, et al.
Published: (2016-08-01)

Investigation of the drug «Cycloferon» influence on the morbidity of acute respiratory viral infections and flu and condition of local immunity in children of different age groups
by: Ye. I. Kondratieva, et al.
Published: (2006-06-01)

Sepsis therapies: learning from 30 years of failure of translational research to propose new leads
by: Jean‐Marc Cavaillon, et al.
Published: (2020-03-01)

Up-to-Date Approach to Treatment of Inflammatory Infections in the Maxillofacial Region
by: M. G. Romantsov, et al.
Published: (2020-05-01)

Immunomodulators in Maintenance Therapy of Tuberculosis With Its Patomorphosis Features Taken Into Consideration
by: V. M. Kolomiets, et al.
Published: (2020-05-01)

Aspects of the formation of encephalopathy and myocardiopathy in sepsis
by: M. V. Petrova, et al.
Published: (2023-10-01)

Research progress on the pathogenesis of acute lung injury in sepsis
by: WANG Qin，YU Xu，LI Qingying，LU Yibin
Published: (2025-08-01)

IMMUNOLOGICAL FEATURES OF SEPSIS PHENOTYPES AND ENDOTYPES
by: Mariia B. Potapova, et al.
Published: (2019-08-01)

Role of Intraosteal Administration of Antibiotics in Treatment of Local Oral Mucinous Carcinoma
by: V. M. Ivanov, et al.
Published: (2020-05-01)

Metabolomic and cytokine profiles of high-risk sepsis phenotypes in children
by: Ryan R. Hurtado, et al.
Published: (2025-07-01)

Antibacterial therapy of sepsis in extracorporeal detoxication: current problems and ways to solve them
by: A. V. Marukhov, et al.
Published: (2020-12-01)

Lipid nanoparticles from L. meyenii Walp mitigate sepsis through multimodal protein corona formation
by: Junsik J. Sung, et al.
Published: (2025-06-01)

Comparative Efficacy of Etiotropic Therapy of Patients with HBeAg-Positive Chronic Hepatitis B (by the Data of the International Comparative Placebo-Controlled Study)
by: V. V. Stelmakh, et al.
Published: (2020-05-01)

Frequently Ill Child Syndrome
by: M. G. Romantsov, et al.
Published: (2020-05-01)

Ways of increase of tolerance of, and adherence to antibacterial therapy
by: A. V. Vorontsova, et al.
Published: (2021-06-01)

MYOCARDIAL DYSFUNCTION IN SEPSIS PATIENTS
by: L. L. Plotkin, et al.
Published: (2018-01-01)

ENDOGENOUS INTOxICATION AND SEPSIS
by: I. V. Aleksandrova, et al.
Published: (2016-02-01)